Purpose Breast cancer-related lymphedema (BCRL) represents a lifelong risk for breast
cancer survivors and once acquired becomes a lifelong burden. This review summarizes …

Background Lymphedema affects one in six breast cancer survivors making it a global
healthcare challenge. There is considerable debate about the efficacy of different treatments …

Background To evaluate risk factors (treatment‐related, comorbidities, and lifestyle) for
breast cancer–related lymphedema (BCRL) within the context of a Prospective Surveillance …

Upper-limb lymphedema is a chronic condition characterized by the accumulation of
lymphatic fluid in the arm or hand, resulting in swelling and functional impairment. The …

Background Breast cancer-related lymphedema (BCRL) affects about 3 to 5 million patients
worldwide, with about 20,000 per year in the United States. As breast cancer mortality is …

As the prognosis of early breast cancer (BC) continues to improve, patients and physicians
are increasingly focused on post-treatment quality of life (QOL). Despite great efforts to de …

Lymphedema and specifically cancer-related lymphedema is not the main focus for both
patients and physicians dealing with cancer. Its etiology is an unfortunate complication of …

PURPOSE The PREVENT randomized trial assessed progression to chronic breast cancer–
related lymphedema (cBCRL) after intervention triggered by bioimpedance spectroscopy …

Purpose The primary aim of this study was to compare the attendance rates at a group
lymphoedema education and same-day individual surveillance appointment between …

Purpose Breast cancer–related lymphedema (BCRL) represents a dreaded complication of
breast cancer treatment that can lead to morbidity, diminished quality of life, and …